chrX-21967312-G-A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PS3PM2PP2PP3_ModeratePP5_Very_Strong
The NM_004595.5(SMS):c.166G>A(p.Gly56Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000262966: "In an assay testing SMS function, this variant showed a functionally abnormal result" (Zhang, 2010)." and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. G56G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004595.5 missense
Scores
Clinical Significance
Conservation
Publications
- syndromic X-linked intellectual disability Snyder typeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004595.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMS | TSL:1 MANE Select | c.166G>A | p.Gly56Ser | missense | Exon 2 of 11 | ENSP00000385746.2 | P52788-1 | ||
| SMS | c.166G>A | p.Gly56Ser | missense | Exon 2 of 12 | ENSP00000523948.1 | ||||
| SMS | c.166G>A | p.Gly56Ser | missense | Exon 2 of 12 | ENSP00000625958.1 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 21
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at